Literature DB >> 2644456

Reperfusion pulmonary edema.

J M Klausner1, I S Paterson, J A Mannick, R Valeri, D Shepro, H B Hechtman.   

Abstract

Reperfusion following lower-torso ischemia in humans leads to respiratory failure manifest by pulmonary hypertension, hypoxemia, and noncardiogenic pulmonary edema. The mechanism of injury has been studied in the sheep lung lymph preparation, where it has been demonstrated that the reperfusion resulting in pulmonary edema is due to an increase in microvascular permeability of the lung to protein. This respiratory failure caused by reperfusion appears to be an inflammatory reaction associated with intravascular release of the chemoattractants leukotriene B4 and thromboxane. Histological studies of the lung in experimental animals revealed significant accumulation of neutrophils but not platelets in alveolar capillaries. We conclude that thromboxane generated and released from the ischemic tissue is responsible for the transient pulmonary hypertension. Second, it is likely that the chemoattractants are responsible for leukosequestration, and, third, neutrophils, oxygen-derived free radicals, and thromboxane moderate the altered lung permeability.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2644456

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

Review 1.  Ischemia and reperfusion--from mechanism to translation.

Authors:  Holger K Eltzschig; Tobias Eckle
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Role of beta 2 integrins and ICAM-1 in lung injury following ischemia-reperfusion of rat hind limbs.

Authors:  A Seekamp; M S Mulligan; G O Till; C W Smith; M Miyasaka; T Tamatani; R F Todd; P A Ward
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

3.  Smoke inhalation causes a delayed increase in airway blood flow to primarily uninjured lung areas.

Authors:  H M Loick; L D Traber; J C Stothert; D N Herndon; D L Traber
Journal:  Intensive Care Med       Date:  1995-04       Impact factor: 17.440

Review 4.  Therapeutic strategies for ischemia reperfusion injury in emergency medicine.

Authors:  Hiromichi Naito; Tsuyoshi Nojima; Noritomo Fujisaki; Kohei Tsukahara; Hirotsugu Yamamoto; Taihei Yamada; Toshiyuki Aokage; Tetsuya Yumoto; Takaaki Osako; Atsunori Nakao
Journal:  Acute Med Surg       Date:  2020-04-13

Review 5.  Pannexin 1 as a driver of inflammation and ischemia-reperfusion injury.

Authors:  Michael Koval; Aleksandra Cwiek; Thomas Carr; Miranda E Good; Alexander W Lohman; Brant E Isakson
Journal:  Purinergic Signal       Date:  2021-07-12       Impact factor: 3.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.